1- Carroll CL BR, Feldman SR, Fleischer AB, Manuel CL. The burden of atopic dermatitis: impact on the patient, family, and society. Pediatr Dermatol. 2005; 22(3): 192-9.
2- Burns DA CN. Introduction and historical bibliography. Oxford: Wiley- Blackwell. 2001; 1(1):
3- Chen SC BA, Soon SL, Aftergut K, Cruz P, Sexton SA. A catalogue of dermatology utilities: a measure of the burden of skin diseases. J Investig Dermatol Symp. 2004; 9: 160-8.
4- Hay R BS, Chen S, Estrada R, Haddix A. Skin diseases. New York: Oxford University Press. 2006; 1(1): 707-22.
5- Walker N L-JM. Quality of life and acne in Scottish adolescent schoolchildren: use of the Children's Dermatology Life Quality Index [CDLQI] and the Cardiff Acne Disability Index [CADI]. J Eur Acad Dermatol Venereol. 2006; 20(1): 45-50.
6- Mease PhJ MA. Quality of life issues in psoriasis and psoriatic arthritis: Outcome measures and therapies from a dermatological perspective. J Am Acad Dermatol. 2006; 54(4): 685-704.
7- Gudjonss JE EJPIWK, Goldsmith LA, Katz S,. Fitzpatrick’s dermatology in general medicine. US: McGraw-Hill. 2008; 1: 169-206.
8- Bolognia JL JJ, Schaffer JV. Textbook of Dermatology. Spain: Mosby Elsevier publishing. 2010; 1.
9- Griffiths CEM BJ. Psoriasis. USA: Blackwell publishi. 2008; 20: 1-20.
10- L N. Epidemiology of psoriasis. Curr Drug Targets Inflamm Allergy. 2004; 1(3(2)): 121-8.
11- Langley RG PA, Hebert AA. Patient-reported outcomes in pediatric patients with psoriasis undergoing etanercept treatment: 12-week results from a phase III randomized controlled trial. J Am Acad Dermatol. 2011; 64(1): 64-70.
12- L F. An Atlas of Psoriasis. New Jersey: USA the Parthenon publishing group Inc. 1997; 1: 1-32.
13- Schmitt J FD. Understanding the relationship between objective disease severity, psoriatic symptoms, illness-related stress, health-related quality of life and depressiven symptoms in patients with psoriasis a structural equations modeling approach. Gen Hosp Psychiatry. 2007; 29(2): 134-40.
14- Gupta AM GK. Evaluation of cutaneous body image dissatisfaction in the dermatology patient. Clin Dermatol. 2013; 31(1): 72-9.
15- Erberk-Ozen N BA, Boratav C, Kocak M. Executive dysfunctions and depression in Behçet's disease without explicit neurological involvement. Psychiatry Clin Neurosci. 2006; 60(4): 465-72.
16- Mercan S K-AI. Psychodermatology: A collaboration between psychiatry and dermatology. Turk Psikiyatri Derg. 2006; 17: 305-13.
17- Ciuluvica C AP, & Fulcheri M. Emotion Regulation Strategies and Quality of Life in Dermatologic Patients. Procedia Soc Behav Sci. 2014; 22(127): 661-5.
18- Chen J XT, Jing J, & Chan RCK. Alexithymia and emotional regulation: A cluster analytical approach. BMC Psychiatry. 2011; 11(1): 33.
19- Dunn LK ONJ, & Feldman SR. Acne in adolescents: quality of life, self-esteem, mood, and psychological disorders. Dermatol Online J. 2011; 17(1): 1.
20- Gee NS ZL, Keuthen N, Kroshinsky D, & Kimball BA. A survey assessment of the recognition and treatment of psychocutaneous disorders in the outpatient dermatology setting: How prepared are we? J Am Acad Dermatol. 2013; 68(1): 47-52.
21- Margalit D B-HL, Brill S, & Vatine JJ. Complex regional pain syndrome, alexithymia, and psychological distress. J Psychosom Res. 2014; 77(4): 273-7.
22- Millard LG CJ. Psychocutaneus disorders. Turin: Blackwell Publishing. 2004; 61: 23-61.
23- Orion E WR. Psychologic factors in the development of facial dermatoses. Clin Dermatol. 2014; 32(6): 763-6.
24- Fortune DG, Helen L. Richards, and Christopher EM Griffiths. Psychologic factors in psoriasis: consequences, mechanisms, and interventions. Clin Dermatol. 2005; 23(4): 681-94.
25- Picardi A ME, Gaetano P, Cattaruzza MS, Baliva G, Melchi CF. Stress, social support, emotional regulation, and exacerbation of diffuse plaque psoriasis. Psychosomatics. 2005; 46(6): 556-64.
26- Picardi A P, P, Cattaruzza, MS, Gaetano P, Melchi CF, Baliva G. Stressful life events, social support, attachment security and alexithymia in vitiligo: A case–control study. Psychother Psychosom. 2003; 72(3): 151-8.
27- Picardi A PP, Cattaruzza MS, Gaetano P, Melchi CF, Baliva, G. Stressfull life events, social support, attachment security, and alexythymia in vitiligo: a case-control study. Psychother Psychosom. 2003; 72(3): 150-8.
28- Picardi A PP, Cattaruzza MS, Gaetano P, Baliva G, Melchi CF. Only limited support for a role of psychosomatic factors in psoriasis: results from a case-control study. J Psychosom Res. 2003; 55(3): 189-96.
29- Picardi A PP, Cattaruzza MS, Gaetano P, Baliva G, Melchi CF. Psychosomatic factors in first-onset alopecia areata. Psychosomatics. (5)44: 20-374
30- PE S. Alexithymia, clinical issues, politics and crime. Psychother Psychosom. 2000; 69(3): 113-6.
31- S K. The psychosemantic approach to alexithymia. Pers Individ Dif. 2002; 33: 393-407.
32- Ciuluvica C AP, & Fulcheri M. Emotion Regulation Strategies and Quality of Life in Dermatologic Patients. Procedia Soc Behav Sci. 2014; 127: 661-5.
33- Campbell-Sills L BD. Incorporating emotion regulation into conceptualizations and treatments of anxiety and mood disorders. New York: Guilford Press. 2007; 1: 542-59
34- JJ G. Emotion regulation: Affective, Cognitive, and Social Consequences. J PSYCHOPATHOL BEHAV. 2002; 26: 41-54.
35- Cole PM MS, Dennis TA. Emotion regulation as a scientific construct: Methodological challenges and directions for child development research. Child Dev. 2004; 75(2): 317-33.
36- JJ G. Emotion regulation: Affective, cognitive, and social consequences. Psychophysiology. 2003; 39: 281-91.
37- B M. Interpersonal emotion regulation as a mechanism of social support in depression. Clin Psychol Rev. 2011; 31(8): 1276-90.
38- Gross JJ TR. Emotion Regulation, Conceptual Foundation. Handbook of Emotion Regulation. New York: Guilford Press. 2007; 1: 3-24.
39- Bagby RM PJ, & Taylor GJ. The twenty-item Toronto Alexithymia Scale: I Item selection and cross-validation of the factor structure. J Psychosom Res. 1994; 38(1): 23-32.
40- M TGB. New trends in alexithymia research. Psychother Psychosom. 2004; 73(1): 68-77.
41- Palmer BR GG, Manocha R, & Syough C. A psychometric evaluation of the Mayer-Salovey-Caruso Emotional Intelligence Test Version 2.0. Intelligence. 2004; 33: 285-305.
42- Parker JDA TG, & Bagby RM. The relationship between emotional intelligence and alexithymia. Pers Individ Dif. 2001; 30: 107-15.
43- Parker JDA TG, & Bagby RM. The 20-item Toronto Alexithymia Scale: III reliability and factorial validity in a community population. J Psychosom Res. 2003; 55: 269-75.
44- Taylor GJ BM. An overview of the alexithymia construct. San Francisco: Jossey-Bass. 2000; 1: 263-76.
45- MA B. Reliability and factorial validity of Farsi version of the Toronto Alexithymia Scale with a sample of Iranian students. Psychol Re. 2007; 101(1): 209-20.
46- First MB S, RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Axis I Disorders [SCID-I], Clinitian Version. Washington, DC: American Psychiatric Association. 1997; 1: 1.
47- G G-M. Handbook of psychological assessment. Hoboken, New Jersey: John Wiley & Sons. 2009; 1: 1.
48- Zanarini MC VA, Parachini EA, Boulanger JL, Frankenburg FR, Hennen J. Zanarini Rating Scale for Borderline Personality Disorder [ZAN-BPD]: a continuous measure of DSM-IV borderline psychopathology. J Pers Disord. 2003; 17(3): 233-42.
49- Sharifi V AM, Amini H, Kaviani H, Semnani Y, Shabani A, Shahrivar Z, Davari Ashtiani R, Hakim Shoshtari M, Seddigh A, & Jalali Roodsari M. Reliability and applicability of the Persian version of the diagnostic structured interview for DSM-IV [SCID]. J Cognitive Neurosci. 2003; 6(1&2): 10-22.
50- Hasani J HM, & Ghaedniay Jahromi A. Complete package of processing emotion regulation strategies training [PERST] based on Gross Model. unpublished. 2011.
51- Cooper JO HT, & Heward WL. Applied behavior analysis. 2007: 37-46.
52- Garnefski N BN, Kraaij V. Psychological distress and cognitive emotion regulation strategies among farmers who fell victim to the foot-and-mouth crisis. Pers Individ Dif. 2005; 38: 1317-27.
53- Kamphuis JH TM. Effects of distraction and guided threat reappraisal on fear reduction during exposure based treatments for specific fears. Behav Res Ther. 2000; 38: 1163-81.
54- Dubey A PR, & Mishra K. Role of emotion regulation difficulties and positive/negative affectivity in explaining alexithymia-health relationship: An overview. J Soc Sci Res. 2012; 7(1): 20-31.
55- Aldao A N-HS, & Schweizer S. Emotion-regulation strategies across psychopathology: A meta-analytic review. Clinical Psychology Review. 2010; 30: 237-17.
56- Cisler JM OB, Feldner MT, & Forsyth JP. Emotion regulation and the anxiety disorders: an integrative review. J Psychopathol Behav Assess. 2010; 1(32): 68-82.
57- Garnefski N KV. Cognitive emotion regulation questionnaire development of a short 18- item version (CERQ-short). Pers Individ Dif. 2009; 41: 1045-53.
58- Grynberg D LO, Corneille O, Grezes J, & Berthoz S. Alexithymia in the interpersonal domain:
A general deficit of empathy? Personality and Individual Differences. 2010; 49: 845-50.
59- Gross JJ JO. Individual differences in two emotion regulation processes: implications for affect, relationships, and well-being. J Pers Soc Psychol. 2003; 85: 348-62.
60- Garnefski N KV. Relationship between cognitive emotion regulation strategies and depressive symptoms: A comparative study of five specific samples. Personality and Individual Differences. 2006; 40: 1659-69.
61- Alloy LB RJ. Cognitive vulnerability to emotional disorders. Routledge. 2006; 1: 1.